227 related articles for article (PubMed ID: 24171719)
21. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
[TBL] [Abstract][Full Text] [Related]
22. Activation of the canonical Wnt/β-catenin pathway in ATF3-induced mammary tumors.
Yan L; Della Coletta L; Powell KL; Shen J; Thames H; Aldaz CM; MacLeod MC
PLoS One; 2011 Jan; 6(1):e16515. PubMed ID: 21304988
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer.
Pond AC; Herschkowitz JI; Schwertfeger KL; Welm B; Zhang Y; York B; Cardiff RD; Hilsenbeck S; Perou CM; Creighton CJ; Lloyd RE; Rosen JM
Cancer Res; 2010 Jun; 70(12):4868-79. PubMed ID: 20501844
[TBL] [Abstract][Full Text] [Related]
24. beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland.
Michaelson JS; Leder P
Oncogene; 2001 Aug; 20(37):5093-9. PubMed ID: 11526497
[TBL] [Abstract][Full Text] [Related]
25. β-Catenin is required for Ron receptor-induced mammary tumorigenesis.
Wagh PK; Gray JK; Zinser GM; Vasiliauskas J; James L; Monga SP; Waltz SE
Oncogene; 2011 Aug; 30(34):3694-704. PubMed ID: 21423209
[TBL] [Abstract][Full Text] [Related]
26. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
[TBL] [Abstract][Full Text] [Related]
27. Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice.
Klinakis A; Szabolcs M; Politi K; Kiaris H; Artavanis-Tsakonas S; Efstratiadis A
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9262-7. PubMed ID: 16751266
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterizations of Nop16 in murine mammary tumors with varying levels of c-Myc.
Kundel DW; Stromquist E; Greene AL; Zhdankin O; Regal RR; Rose-Hellekant TA
Transgenic Res; 2012 Apr; 21(2):393-406. PubMed ID: 21863248
[TBL] [Abstract][Full Text] [Related]
29. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers.
Weng D; Penzner JH; Song B; Koido S; Calderwood SK; Gong J
Breast Cancer Res; 2012 Jan; 14(1):R18. PubMed ID: 22277639
[TBL] [Abstract][Full Text] [Related]
30. Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates beta-catenin signaling in mammary epithelial cells.
Su Y; Simmen RC
Carcinogenesis; 2009 Feb; 30(2):331-9. PubMed ID: 19073877
[TBL] [Abstract][Full Text] [Related]
31. Rspo2/Int7 regulates invasiveness and tumorigenic properties of mammary epithelial cells.
Klauzinska M; Baljinnyam B; Raafat A; Rodriguez-Canales J; Strizzi L; Greer YE; Rubin JS; Callahan R
J Cell Physiol; 2012 May; 227(5):1960-71. PubMed ID: 21732367
[TBL] [Abstract][Full Text] [Related]
32. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
[TBL] [Abstract][Full Text] [Related]
33. Selective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesis.
Wu L; de Bruin A; Wang H; Simmons T; Cleghorn W; Goldenberg LE; Sites E; Sandy A; Trimboli A; Fernandez SA; Eng C; Shapiro C; Leone G
Oncogene; 2015 Jan; 34(1):119-28. PubMed ID: 24276244
[TBL] [Abstract][Full Text] [Related]
34. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.
Prosperi JR; Goss KH
Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611
[TBL] [Abstract][Full Text] [Related]
35. The BCL9-2 proto-oncogene governs estrogen receptor alpha expression in breast tumorigenesis.
Zatula N; Wiese M; Bunzendahl J; Birchmeier W; Perske C; Bleckmann A; Brembeck FH
Oncotarget; 2014 Aug; 5(16):6770-87. PubMed ID: 25149534
[TBL] [Abstract][Full Text] [Related]
36. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.
Schwab LP; Peacock DL; Majumdar D; Ingels JF; Jensen LC; Smith KD; Cushing RC; Seagroves TN
Breast Cancer Res; 2012 Jan; 14(1):R6. PubMed ID: 22225988
[TBL] [Abstract][Full Text] [Related]
38. Wnt/β-catenin signaling is critical for dedifferentiation of aged epidermal cells in vivo and in vitro.
Zhang C; Chen P; Fei Y; Liu B; Ma K; Fu X; Zhao Z; Sun T; Sheng Z
Aging Cell; 2012 Feb; 11(1):14-23. PubMed ID: 21967252
[TBL] [Abstract][Full Text] [Related]
39. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
[TBL] [Abstract][Full Text] [Related]
40. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]